132 related articles for article (PubMed ID: 20885008)
1. Evaluation of terfenadine and ketoconazole-induced QT prolongation in conscious telemetered guinea pigs.
Rajput SK; Singh JN; Sharma SS
Pharmacol Rep; 2010; 62(4):683-8. PubMed ID: 20885008
[TBL] [Abstract][Full Text] [Related]
2. Aging-related changes of QT and RR intervals in conscious guinea pigs.
Shiotani M; Harada T; Abe J; Hamada Y; Horii I
J Pharmacol Toxicol Methods; 2008; 57(1):23-9. PubMed ID: 17889568
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the QT interval response during sinus and paced rhythm in conscious and anesthetized beagle dogs.
Ollerstam A; Visser SA; Duker G; Forsberg T; Persson AH; Nilsson LB; Björkman JA; Gabrielsson J; Al-Saffar A
J Pharmacol Toxicol Methods; 2007; 56(2):131-44. PubMed ID: 17689270
[TBL] [Abstract][Full Text] [Related]
4. Cardiotoxic and drug interaction profile of the second generation antihistamines ebastine and terfenadine in an experimental animal model of torsade de pointes.
Hey JA; del Prado M; Kreutner W; Egan RW
Arzneimittelforschung; 1996 Feb; 46(2):159-63. PubMed ID: 8720305
[TBL] [Abstract][Full Text] [Related]
5. Practical application of guinea pig telemetry system for QT evaluation.
Shiotani M; Harada T; Abe J; Sawada Y; Hashimoto K; Hamada Y; Horii I
J Toxicol Sci; 2005 Aug; 30(3):239-47. PubMed ID: 16141657
[TBL] [Abstract][Full Text] [Related]
6. QT prolongation in guinea pigs for preliminary screening of torsadogenicity of drugs and drug-candidates. II.
Testai L; Breschi MC; Martinotti E; Calderone V
J Appl Toxicol; 2007; 27(3):270-5. PubMed ID: 17265420
[TBL] [Abstract][Full Text] [Related]
7. Methodological validation of an existing telemetry system for QT evaluation in conscious guinea pigs.
Shiotani M; Harada T; Abe J; Hamada Y; Horii I
J Pharmacol Toxicol Methods; 2007; 55(1):27-34. PubMed ID: 16831559
[TBL] [Abstract][Full Text] [Related]
8. QT and RR intervals in conscious and anesthetized guinea pigs with highly varying RR intervals and given QTc-lengthening test articles.
Hamlin RL; Kijtawornrat A; Keene BW; Hamlin DM
Toxicol Sci; 2003 Dec; 76(2):437-42. PubMed ID: 14600288
[TBL] [Abstract][Full Text] [Related]
9. Calculation of QT shift in non clinical safety pharmacology studies.
Champeroux P; Martel E; Fowler JS; Maurin A; Sola ML; Jude S; Elamrani F; Weyn AA; Laveissiere A; Lala P; Richard S
J Pharmacol Toxicol Methods; 2009; 59(2):73-85. PubMed ID: 19135537
[TBL] [Abstract][Full Text] [Related]
10. A novel approach to data processing of the QT interval response in the conscious telemetered beagle dog.
Ollerstam A; Persson AH; Visser SA; Fredriksson JM; Forsberg T; Nilsson LB; Eklund G; Wiklund SJ; Gabrielsson J; Duker G; Al-Saffar A
J Pharmacol Toxicol Methods; 2007; 55(1):35-48. PubMed ID: 16581270
[TBL] [Abstract][Full Text] [Related]
11. ECG telemetry in conscious guinea pigs.
Ruppert S; Vormberge T; Igl BW; Hoffmann M
J Pharmacol Toxicol Methods; 2016; 81():88-98. PubMed ID: 27118261
[TBL] [Abstract][Full Text] [Related]
12. Problems of heart rate correction in assessment of drug-induced QT interval prolongation.
Malik M
J Cardiovasc Electrophysiol; 2001 Apr; 12(4):411-20. PubMed ID: 11332559
[TBL] [Abstract][Full Text] [Related]
13. QT PRODACT: in vivo QT assay with a conscious monkey for assessment of the potential for drug-induced QT interval prolongation.
Ando K; Hombo T; Kanno A; Ikeda H; Imaizumi M; Shimizu N; Sakamoto K; Kitani S; Yamamoto Y; Hizume S; Nakai K; Kitayama T; Yamamoto K
J Pharmacol Sci; 2005; 99(5):487-500. PubMed ID: 16493189
[TBL] [Abstract][Full Text] [Related]
14. Accurate detection of drug-induced delayed ventricular repolarization with a suitable correction formula in Langendorff guinea pig heart.
Tabo M; Komatsu R; Isobe T; Honda M; Yamada Y; Kimura K
J Toxicol Sci; 2010 Oct; 35(5):687-98. PubMed ID: 20930463
[TBL] [Abstract][Full Text] [Related]
15. Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation.
Takahara A; Sugiyama A; Hashimoto K
Br J Pharmacol; 2005 Oct; 146(4):561-7. PubMed ID: 16056235
[TBL] [Abstract][Full Text] [Related]
16. The relationship of clinical QT prolongation to outcome in the conscious dog using a beat-to-beat QT-RR interval assessment.
Fossa AA; DePasquale MJ; Raunig DL; Avery MJ; Leishman DJ
J Pharmacol Exp Ther; 2002 Aug; 302(2):828-33. PubMed ID: 12130750
[TBL] [Abstract][Full Text] [Related]
17. Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin.
Holzgrefe HH; Cavero I; Buchanan LV; Gill MW; Durham SK
J Pharmacol Toxicol Methods; 2007; 55(3):227-37. PubMed ID: 17097307
[TBL] [Abstract][Full Text] [Related]
18. Interferences of the autonomic nervous system with drug induced QT prolongation: a point to consider in non-clinical safety studies.
Champeroux P; Ouillé A; Martel E; Fowler JS; Maurin A; Jude S; Lala P; Le Guennec JY; Richard S
J Pharmacol Toxicol Methods; 2010; 61(3):251-63. PubMed ID: 20172034
[TBL] [Abstract][Full Text] [Related]
19. Preclinical QT safety assessment: cross-species comparisons and human translation from an industry consortium.
Holzgrefe H; Ferber G; Champeroux P; Gill M; Honda M; Greiter-Wilke A; Baird T; Meyer O; Saulnier M
J Pharmacol Toxicol Methods; 2014; 69(1):61-101. PubMed ID: 23689033
[TBL] [Abstract][Full Text] [Related]
20. Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences.
Honig PK; Wortham DC; Zamani K; Conner DP; Mullin JC; Cantilena LR
JAMA; 1993 Mar 24-31; 269(12):1513-8. PubMed ID: 8445813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
